Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taurine up-regulated 1 (TUG1) is a highly conserved long non-coding RNA (lncRNA) located on chromosome 22q12.2, originally identified for its essential role in retinal development (PMID: 15802262). It functions as a molecular scaffold, interacting with the Polycomb Repressive Complex 2 (PRC2) to mediate epigenetic gene silencing and chromatin remodeling (PMID: 24703830). Additionally, TUG1 acts as a competitive endogenous RNA (ceRNA) or 'molecular sponge' that sequesters various microRNAs, thereby preventing them from inhibiting their target mRNAs and influencing pathways such as Wnt/beta-catenin and PI3K/Akt (PMID: 31110605). In clinical oncology, TUG1 is predominantly characterized as an oncogene, where its overexpression is linked to increased cell proliferation, migration, and poor prognosis in malignancies like glioblastoma and non-small cell lung cancer (PMID: 28656234). Beyond cancer, it is also implicated in metabolic diseases, notably showing protective roles in diabetic nephropathy when properly regulated. Therapeutic development currently focuses on using antisense oligonucleotides (ASOs) to trigger the degradation of TUG1 transcripts, aiming to suppress tumor growth and restore normal gene expression patterns (NCBI Gene ID: 55057).
Antisense-mediated RNA degradation and RNA interference (RNAi) to reduce oncogenic lncRNA levels.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taurine up-regulated 1 (TUG1).